Novacyt (FR:ALNOV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Novacyt S.A., an international specialist in clinical diagnostics, announced a settlement with the UK’s Department of Health and Social Care involving a £5.0m payment, which is expected to result in a £7m net cash increase following a VAT reclaim. The update, presented ahead of their Annual General Meeting, will affect the company’s 2024 Interim Accounts with a net loss of approximately £5.0m. Novacyt’s stock market presence includes listings on the Euronext Growth Paris and London’s AIM.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
